海西新药(02637)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02637 海西新药

已收盘 12-05 16:09:06

130.200

+0.200

+0.15%

最高131.100	最低128.400	成交量7.55万
今开130.100	昨收130.000	日振幅2.08%
总市值102.48亿	流通市值102.48亿	总股本7,871万
成交额982.28万	换手率0.10%	流通股本7,871万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02637","market":"HK","secType":"STK","nameCN":"海西新药","latestPrice":130.2,"timestamp":1764922146480,"preClose":130,"halted":0,"volume":75450,"delay":0,"floatShares":78707270,"shares":78707270,"eps":2.230063410973407,"marketStatus":"已收盘","change":0.2,"latestTime":"12-05 16:09:06","open":130.1,"high":131.1,"low":128.4,"amount":9822835,"amplitude":0.020769,"askPrice":130.4,"askSize":50,"bidPrice":130.2,"bidSize":300,"shortable":0,"etf":0,"ttmEps":2.230063410973407,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":5,"adr":0,"listingDate":1760889600000,"exchange":"SEHK","adjPreClose":130,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":1.036543,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02637","defaultTab":"news","newsList":[{"id":"2588234600","title":"海西新药12月03日获主力加仓17.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588234600","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588234600?lang=zh_cn&edition=full","pubTime":"2025-12-03 16:15","pubTimestamp":1764749738,"startTime":"0","endTime":"0","summary":"12月03日, 海西新药股价涨2.39%，报收132.90元，成交金额896.8万元，换手率0.09%，振幅3.70%，量比0.95。海西新药今日主力资金净流入17.8万元，上一交易日主力净流入8.0万元。该股近5个交易日上涨4.56%，主力资金累计净流入10.1万元；近20日主力资金累计净流入541.2万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161829952866da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203161829952866da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2585113389","title":"海西新药(02637)：林慧怡获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2585113389","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585113389?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:37","pubTimestamp":1763714228,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海西新药(02637)发布公告，陈晓琳女士已辞任(i)公司联席公司秘书;(ii) 《香港联合交易所有限公司证券上市规则》第3.05条项下所规定的公司授权代表;(iii)根据香港法例第622章《公司条例》第16部项下的公司授权代表;及 (iv)上市规则第19A.13(2)条所规定代公司在香港接收法律程序文件及通知书的公司授权人士，自2025年11月21日起生效。林慧怡女士已获委任为联席公司秘书、授权代表及法律程序代理人，自2025年11月21日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1372061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2584359071","title":"海西新药11月20日主力净流入6.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2584359071","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584359071?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:16","pubTimestamp":1763626564,"startTime":"0","endTime":"0","summary":"11月20日, 海西新药股价涨1.96%，报收130.00元，成交金额833.3万元，换手率0.08%，振幅7.84%，量比1.19。海西新药今日主力资金净流入6.6万元，上一交易日主力净流出0万元。该股近5个交易日下跌8.43%，主力资金累计净流出35.6万元；近20日主力资金累计净流入1254.3万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120162339951035b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120162339951035b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02637"],"gpt_icon":0},{"id":"1155189587","title":"海西新药涨超10%再创新高，较招股价涨近七成！四款核心仿制药贡献九成收入","url":"https://stock-news.laohu8.com/highlight/detail?id=1155189587","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155189587?lang=zh_cn&edition=full","pubTime":"2025-11-12 14:43","pubTimestamp":1762929801,"startTime":"0","endTime":"0","summary":"11月12日，$海西新药$涨超10%再创新高，较招股价涨近七成！公开资料显示，海西新药是一家处于商业化阶段的制药公司。截至招股书披露日，海西新药获批上市的仿制药产品有15款，产品组合涵盖了多个治疗领域，包括消化系统、心血管系统、内分泌系统、神经系统等。从2024年的营收情况看，这四款核心仿制药贡献了海西新药超过九成的收入，达到4.25亿元。值得注意的是，海西新药已布局创新药研发管线。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2e9a463070c3ede9e070dabbce786938","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2582344262","title":"港股异动 | 海西新药(02637)涨超10%再创新高 较招股价涨近七成 四款核心仿制药贡献九成收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2582344262","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582344262?lang=zh_cn&edition=full","pubTime":"2025-11-12 14:36","pubTimestamp":1762929418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海西新药午后涨超10%，高见145.9港元，再创上市新高，较招股价86.4港元累涨近70%。公开资料显示，海西新药是一家处于商业化阶段的制药公司。截至招股书披露日，海西新药获批上市的仿制药产品有15款，产品组合涵盖了多个治疗领域，包括消化系统、心血管系统、内分泌系统、神经系统等。从2024年的营收情况看，这四款核心仿制药贡献了海西新药超过九成的收入，达到4.25亿元。值得注意的是，海西新药已布局创新药研发管线。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2e9a463070c3ede9e070dabbce786938","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368180.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637","BK1191"],"gpt_icon":0},{"id":"2582801415","title":"海西新药11月10日获主力加仓193.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582801415","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582801415?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:15","pubTimestamp":1762762523,"startTime":"0","endTime":"0","summary":"11月10日, 海西新药股价涨5.37%，报收129.40元，成交金额1627.1万元，换手率0.16%，振幅7.74%，量比1.10。海西新药今日主力资金净流入193.3万元，连续4日净流入，上一交易日主力净流入169.9万元。该股近5个交易日上涨7.28%，主力资金累计净流入841.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1095.3万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161643975fcd7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110161643975fcd7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637","BK1191"],"gpt_icon":1},{"id":"2579187071","title":"海西新药10月30日主力净流入255.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2579187071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579187071?lang=zh_cn&edition=full","pubTime":"2025-10-30 16:15","pubTimestamp":1761812146,"startTime":"0","endTime":"0","summary":"10月30日, 海西新药股价涨6.80%，报收121.00元，成交金额2544.9万元，换手率0.27%，振幅9.44%，量比1.32。海西新药今日主力资金净流入255.0万元，上一交易日主力净流出2.6万元。该股近5个交易日上涨18.40%，主力资金累计净流入476.6万元；近20日主力资金累计净流入264.0万元，其中净流入天数为3日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030162022a6d6550d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251030162022a6d6550d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637"],"gpt_icon":0},{"id":"2577593583","title":"海西新药10月24日主力净流出6.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2577593583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577593583?lang=zh_cn&edition=full","pubTime":"2025-10-24 16:15","pubTimestamp":1761293721,"startTime":"0","endTime":"0","summary":"10月24日, 海西新药股价跌0.45%，报收109.50元，成交金额1026.1万元，换手率0.12%，振幅6.27%，量比0.00。海西新药今日主力资金净流出6.9万元，上一交易日主力净流入273.4万元。该股近5个交易日上涨26.74%，主力资金累计净流入53.9万元；近20日主力资金累计净流入53.9万元，其中净流入天数为2日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024161632a4723cf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024161632a4723cf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02637"],"gpt_icon":0},{"id":"2577332211","title":"港股异动 | 海西新药(02637)一度涨超12% 较招股价涨超三成 仿制药、创新药双线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2577332211","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577332211?lang=zh_cn&edition=full","pubTime":"2025-10-23 14:09","pubTimestamp":1761199757,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，海西新药(02637)一度涨超12% ，高见114.9港元，较招股价86.4港元涨超30%。截至发稿，涨9.2%，报111.6港元，成交额2093.12万港元。据悉，海西新药是一家处于商业化阶段的制药公司，集研发、生产及销售能力于一体，具备在研创新药的管线。截至招股书披露日，海西新药获批上市的仿制药产品有15款，产品组合涵盖了多个治疗领域，包括消化系统、心血管系统、内分泌系统、神经系统等。公司亦已建立四款在研创新药的产品管线，涵盖癌症、眼科及呼吸系统疾病。海西新药此前在招股书中称，未来计划积极探索与跨国公司(MNC)合作的机会，以扩大公司的国际临床研究及商业化能力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358592.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637","BK1161","BK1574","06978","159992"],"gpt_icon":0},{"id":"1174412031","title":"异动解读 | 海西新药盘中大跌5.04%，高度依赖集采产品引发担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1174412031","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174412031?lang=zh_cn&edition=full","pubTime":"2025-10-21 09:52","pubTimestamp":1761011555,"startTime":"0","endTime":"0","summary":"10月21日（周二）上午，港股上市新秀海西新药盘中大跌5.04%，引发市场广泛关注。该公司刚于10月20日在港交所挂牌上市，首日表现亮眼，收盘上涨20.60%。投资者需密切关注海西新药未来的业务转型进展和创新药管线的研发进度，以评估公司的长期发展前景。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4f283e08a8c52a60fffa4beefbde09d3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02637"],"gpt_icon":1},{"id":"1187748903","title":"异动解读 | 海西新药盘中大跌5%，高度依赖集采产品引发担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1187748903","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187748903?lang=zh_cn&edition=full","pubTime":"2025-10-21 09:50","pubTimestamp":1761011444,"startTime":"0","endTime":"0","summary":"港股上市新秀海西新药今日盘中大跌5.04%，引发市场关注。该公司于10月20日刚刚在港交所挂牌上市，首日表现亮眼，收盘上涨20.60%。海西新药是一家商业化阶段的制药公司，主要依赖仿制药销售。尽管海西新药正在布局创新药研发管线，但多数项目仍处于早期临床阶段，短期内难以为公司贡献显著收入。市场分析师指出，海西新药需要加快创新药研发进程，提升研发效率，以在激烈的行业竞争中抢占先机。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4f283e08a8c52a60fffa4beefbde09d3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02637"],"gpt_icon":1},{"id":"1175052573","title":"港股综述｜三大指数齐涨！航空股延续近期涨势，机器人概念股集体“起飞”","url":"https://stock-news.laohu8.com/highlight/detail?id=1175052573","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175052573?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:34","pubTimestamp":1760949292,"startTime":"0","endTime":"0","summary":"A股行情A股收评：强势反弹！创业板指涨近2%，培育钻石、煤炭板块大涨10月20日，A股三大指数今日集体反弹，但午后涨幅有所收窄；截至收盘，沪指涨0.63%报3863点，深证成指涨0.98%，创业板指涨1.98%。全市场成交额1.75万亿元，较前一交易日缩量2031亿元，超4000股上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637","HSTECH","HSI","09988","00670","02670"],"gpt_icon":1},{"id":"1153951196","title":"异动解读 | 海西新药上市首日盘中大涨21.53%，超额认购成热点","url":"https://stock-news.laohu8.com/highlight/detail?id=1153951196","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153951196?lang=zh_cn&edition=full","pubTime":"2025-10-20 09:33","pubTimestamp":1760924003,"startTime":"0","endTime":"0","summary":"海西新药今日在港交所正式挂牌上市，盘中大涨21.53%，引发市场热烈关注。据悉，海西新药此次全球发售1150万股H股，最终发售价定为每股86.40港元，位于招股价区间的上限。公司香港公开发售部分获得3165.1倍超额认购，认购热情异常高涨。海西新药是一家专注于仿制药研发和生产的制药公司，产品涵盖消化系统、心血管系统等多个治疗领域。投资者对公司的增长潜力和市场地位表现出强烈信心，推动股价在首日交易中大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"01fb23fb7463438e1609e2def22b10ca","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02637"],"gpt_icon":0},{"id":"1147192935","title":"异动解读 | 海西新药上市首日大涨21.53%，IPO超额认购3165倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1147192935","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147192935?lang=zh_cn&edition=full","pubTime":"2025-10-20 09:33","pubTimestamp":1760923987,"startTime":"0","endTime":"0","summary":"今日盘中，新上市的制药公司海西新药股价大涨21.53%，引起市场广泛关注。这家备受期待的新股今天正式在港交所挂牌交易，其强劲表现与其火爆的IPO认购情况密切相关。据悉，海西新药此前公布的招股结果显示，公司以每股86.40港元的上限价格定价，募集资金净额约9.4亿港元。分析人士指出，海西新药的强劲表现可能源于其在仿制药市场的领先地位和良好的财务表现。这些因素共同推动了投资者的热情，促使股价在上市首日出现大幅上涨。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"01fb23fb7463438e1609e2def22b10ca","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02637"],"gpt_icon":1},{"id":"1120540781","title":"新股定价 | 海西新药上限定价、今日挂牌，公开发售超购3164倍，一手中签率1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120540781","media":"老虎资讯综合","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120540781?lang=zh_cn&edition=full","pubTime":"2025-10-20 09:03","pubTimestamp":1760922205,"startTime":"0","endTime":"0","summary":"原计划于上周五(17日)上市的 $海西新药(02637)$ (02637.HK)公布招股结果，香港公开发售接获3,165.1倍认购，一手(50股)中签率1%，认购30万股始获稳派一手。国际发售录得6.3倍认购。最终发售价86.4港元，上限定价，集资净额9.4亿元。股份预期今日(20日)挂牌。创新药企海西新药本次拟全球发售1,150万股H股，公开发售占10%。招股价介乎69.88-86.4港元。基石投资者Harvest Oriental SP认购198.17万股，占发售总数17.23%。禁售承诺最后日期2026年4月19日。","market":"hk","thumbnail":"https://static.tigerbbs.com/03b737852f586e2640047e4e68a010a4","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/03b737852f586e2640047e4e68a010a4"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"01fb23fb7463438e1609e2def22b10ca","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"新股定价 | 海西新药上限定价、今日挂牌，公开发售超购3164倍，一手中签率1%","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"gpt_icon":0},{"id":"2576076107","title":"海西新药恢复周一上市，暗盘涨超50%！靠4款核心仿制药年入超4亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576076107","media":"红星资本局","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576076107?lang=zh_cn&edition=full","pubTime":"2025-10-19 20:26","pubTimestamp":1760876807,"startTime":"0","endTime":"0","summary":"红星资本局10月19日消息，10月17日晚，福建海西新药创制股份有限公司（下称“海西新药”）在港交所发布公告称，将于10月20日（星期一）正式上市，发售价格为86.40港元/股。海西新药原定于10月17日在港股正式挂牌交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510193538034414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02637"],"gpt_icon":1},{"id":"1136460264","title":"福建海西新药创制(2637)热度飙升 逾31.6万份认购将于10月20日登陆港交所","url":"https://stock-news.laohu8.com/highlight/detail?id=1136460264","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136460264?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:06","pubTimestamp":1760709979,"startTime":"0","endTime":"0","summary":"福建海西新药创制股份有限公司宣布，全球发售最终发售价确定为每股H股86.40港元。公司本次共发行11,500,000股H股，预期募资总额约为993.60百万港元，扣除约53.47百万港元上市开支后，预计所得款项净额约940.13百万港元。公司股份将于2025年10月20日（星期一）在香港联交所正式挂牌交易，每手买卖单位50股H股。香港发售方面，海西新药本次“火爆认购”有效申请数目316,139份，受理申请21,566份，认购倍数高达3,165.1倍。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02637"],"gpt_icon":1},{"id":"2576097082","title":"到手的“肉签”飞了？海西新药是延迟上市还是被迫中止？","url":"https://stock-news.laohu8.com/highlight/detail?id=2576097082","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576097082?lang=zh_cn&edition=full","pubTime":"2025-10-17 17:23","pubTimestamp":1760693006,"startTime":"0","endTime":"0","summary":"海西新药本预期H股于10月17日上午九时正在联交所开始买卖，所以公司上述公告一出立马引发市场热议。因为与此前首钢朗泽IPO紧急叫停的原因不同，海西新药是在开启暗盘交易后宣布暂缓挂牌。而海西新药也成为自2023年港交所FINI系统落地后，首只在暗盘交易后因未能刊发配发结果而延迟上市的新股公司。据悉，海西新药的创新药管线包括1个2期临床项目、3个临床前项目，覆盖了肿瘤、眼科及呼吸系统疾病领域需求。","market":"hk","thumbnail":"https://static.tigerbbs.com/266ab84342c6ca65b538d0b42bc1dc4e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/266ab84342c6ca65b538d0b42bc1dc4e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66a4019331b03d4321cdeb149dbc6c5b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356368.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"到手的“肉签”飞了？海西新药是延迟上市还是被迫中止？","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637"],"gpt_icon":1},{"id":"2575744597","title":"海西新药(02637)将延迟上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2575744597","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575744597?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:26","pubTimestamp":1760621195,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海西新药(02637)公布，因需要额外时间完成配发结果公告的定稿及获取监管机构批准，公司的上市时间表将会顺延。董事会将在切实可行情况下尽快向市场提供最新资料。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66a4019331b03d4321cdeb149dbc6c5b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02637"],"gpt_icon":0},{"id":"2575744592","title":"海西新药将延迟上市，需额外时间完成公告及获取监管批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2575744592","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575744592?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:26","pubTimestamp":1760621195,"startTime":"0","endTime":"0","summary":"将尽快向市场提供最新资料。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66a4019331b03d4321cdeb149dbc6c5b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"海西新药将延迟上市，需额外时间完成公告及获取监管批准","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02637"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hxpharma.com","stockEarnings":[{"period":"1week","weight":0.0085},{"period":"1month","weight":0.1178},{"period":"3month","weight":0.5046},{"period":"ytd","weight":0.5046}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.0204},{"period":"6month","weight":0.0901},{"period":"1year","weight":0.3137},{"period":"ytd","weight":0.2929}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"福建海西新药创制股份有限公司成立于2012年3月27日。公司是一家处于商业化阶段的制药公司,集研发、生产及销售能力于一体,具备在研创新药的管线。公司在中国最大、增长最快的治疗领域拥有多元化的产品组合及管线。截至最后实际可行日期,公司已商业化的产品组合主要包括用于消化系统疾病、心血管系统疾病、内分泌系统疾病、神经系统疾病及炎症疾病的仿制药。根据灼识咨询的资料,该等治疗领域占2023年中国医药销售总额的25%以上。公司的创新药管线专注于具有各种适应症的在研药物,包括一款潜在属同类首款的在研肿瘤药物、一款潜在用于治疗湿性年龄相关性黄斑变性(wAMD)╱糖尿病性黄斑水肿(DME)╱视网膜静脉阻塞(RVO)的首款口服药物及另外两款处于临床前阶段,用于治疗肿瘤及呼吸系统疾病的创新在研药物。公司所有在研创新药均由内部以专有方式开发及发展。","exchange":"SEHK","name":"海西新药","nameEN":"HAIXI PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海西新药(02637)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海西新药(02637)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海西新药,02637,海西新药股票,海西新药股票老虎,海西新药股票老虎国际,海西新药行情,海西新药股票行情,海西新药股价,海西新药股市,海西新药股票价格,海西新药股票交易,海西新药股票购买,海西新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海西新药(02637)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海西新药(02637)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}